In one of the earliest studies exploring the role of FDG PET/CT in anti-PD1 immunotherapy, Dercle et al. found that among 16 patients with HL, 4 achieved complete metabolic response after 6 months of therapy [61]. This evidence concerns the gene PDCD1 and Hodgkins lymphoma.